Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record describes a completed Phase 1b/2 trial of lenvatinib plus pembrolizumab for selected solid tumors, including eligibility criteria, study locations, outcome measures, publications, and study documents.
    Difference
    80%
    Check dated 2026-11-07T15:47:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:14:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH announcement says that agencies are transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.
    Difference
    1%
    Check dated 2026-10-24T18:22:05.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site's footer revision label changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T22:10:37.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:41.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content. This indicates the page is temporarily inaccessible and blocks access to the study record.
    Difference
    0.5%
    Check dated 2026-09-26T21:44:43.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.